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Autonomic neuropathy, although not rare, is one of the
most insidious complications of diabetes mellitus, especially
in those patients with long-standing and poorly controlled
disease. A lot of attention has been given to the cardio-
vascular aspect of autonomic dysfunction, which has been
implicated in increased mortality, especially in view of recent
reports regarding the association of very tight glycaemic
control with increased mortality, which could be attributed
to hypoglycemia-induced arrhythmias.
However, cardiac autonomic neuropathy is only one of
the many facets of this complication, which leaves virtually
no organ system unaﬀected. In this special issue of the
journal, we have invited authors to submit reviews and
research articles regarding autonomic neuropathy in patients
with diabetes and obesity, since this last condition is also
associated with autonomic dysfunction, due to concomitant
insulin resistance. The issue includes papers on cardiac
autonomic neuropathy, sudomotor dysfunction, skin blood
perfusion, insulin secretion, and exocrine pancreatic insuﬃ-
ciency.
In an extensive and elaborate review, Dr. C. Voulgari
et al. examine the application of a simple, inexpensive, yet
extremely useful tool, the electrocardiogram, in assessing
diabetic patients with possible cardiac autonomic neuropa-
thy and screening them for cardiovascular disease.
In the following research papers, H.-W. Huang et al.
investigate the applicability of using frequency domain
analysis on laser Doppler ﬂowmetry data in the study of
carpal tunnel syndrome and diabetic polyneuropathy, while
N.Papanasetal.examinetheassociationbetweenserumuric
acidlevelsandsudomotordysfunctioninpatientswithtype2
diabetes mellitus and ﬁnd it to be positive, a fact which leads
them to speculation on the potential role of serum uric acid
in sudomotor dysfunction.
Returning to cardiac autonomic function, Dr. S. Liatis et
al. demonstrate that in young patients with type 1 diabetes,
even in the absence of macrovascular and renal complica-
tions, large arterial stiﬀness can be present and diagnosed
with pulse wave velocity analysis, and, furthermore, cardiac
parasympathetic function, as assessed by the classic tests
proposed by Ewing and Clarke, is strongly associated with
this condition, thus highlighting the importance of cardiac
autonomic dysfunction in predicting cardiovascular disease
risk, even in the absence of overt diabetic complications.
Apart from diabetes, obesity, a condition which predis-
poses to diabetes and is characterized by insulin resistance,
hasbeenproposedtobeassociatedwithimpairedautonomic
function. This is addressed in the research paper by Dr.
A. E. Andreazzi et al., in which prediabetic obese rats
are demonstrated to have low sympathoadrenal activity,
which, according to the authors, contributes to glucose
intolerance and hyperinsulinemia during an intravenous
glucose tolerance test.
Finally, Drs. P. D. Hardt and N. Ewald present an elegant
review on exocrine pancreatic insuﬃciency, in which they
address its increased frequency in type 1 and 2 diabetes
and discuss whether it is a complication of the disease or
a concomitant condition to underlying pancreatic diseases2 Experimental Diabetes Research
which also lead to diabetes, and the possible role of diabetic
neuropathy in its manifestation, after carefully guiding the
reader through the relevant literature.
The present special issue should by no means be con-
sidered a comprehensive “primer” on all the facets of
autonomic neuropathy, and this was never its original aim.
The purpose was to present the reader with an update on
as many as possible of the aspects of autonomic dysfunction
in diabetes and obesity, and in these terms, we consider it
to have achieved its goal. We believe that both the research
papers, as well as the review articles contained herein are
of high quality and address key issues in the presentation
and diagnosis of this condition. We hope that this issue will
underscore the importance of autonomic dysfunction as a
condition that is not at all rare, but is often overlooked by
clinicians both in terms of diagnosis as well as treatment and
that it will also serve as a reminder of the need for further
research in this ﬁeld.
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